Ignite Creation Date:
2024-05-06 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05198960
Status:
RECRUITING
Last Update Posted:
2023-10-30
First Post:
2021-11-09
Brief Title:
AVAJAK ApixabanRivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
Sponsor:
Organization:
University Hospital Brest